Saturday, June 07, 2014

No down payment medical, dental and healthcare provider practice financing here! + More News: U.S. FDA approves Biogen's hemophilia A drug Eloctate + MORE 06/07/2014


Medical Professional financing for your medical practice!  Learn how to get funding with medical practice financing. More Info Here!



Call: 904-551-6090




Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.


Read The Interesting Snippets Below For Exciting Health-Care News!





UNITED NATIONS, June 6 (Reuters) – U.N. Secretary-General Ban Ki-moon voiced concerns on Friday about the worsening health of Palestinian hunger strikers in Israeli detention and demanded that they either be formally charged or released immediately.

Continue Reading On http://www.reuters.com »




June 6 (Reuters) – The following U.S.-listed companies reported earnings on Friday. This list shows whether they beat, met or missed Wall Street analysts’ forecasts. It also shows the difference between analysts’ expectations and reported results. The figures are provided by Thomson Reuters I/B/E/S. All revenue amounts are in millions. Company Name Ticker Qtr Industry Curr EPS Est EPS Act Diff EPS Rev Est Rev Act Diff Rev HURCO COMPANIES

Continue Reading On http://www.reuters.com »




(Adds Deutsche Bank, Alitalia, Etihad Airways, Nordion, Uber, Pizza Express, GDF Suez, Exxon Mobil, Commerzbank)

Continue Reading On http://www.reuters.com »




U.S. FDA approves Biogen's hemophilia A drug Eloctate


– http://www.reuters.com/healthNews


WASHINGTON (Reuters) – The U.S. Food and Drug Administration said on Friday it approved Biogen Idec Inc’s long-lasting hemophilia A drug, Eloctate, adding another product to the company’s nascent portfolio of drugs for non-malignant blood disorders.

Continue Reading On http://www.reuters.com/healthNews »




WASHINGTON, June 6 (Reuters) – The U.S. Food and Drug Administration said on Friday it has approved Biogen Idec Inc’s long-lasting hemophilia A drug, Eloctate, adding another product to the company’s nascent portfolio of drugs for non-malignant blood disorders.

Continue Reading On http://www.reuters.com »




SAN ANTONIO, June 6 (Reuters) – The acting secretary of the Department of Veterans Affairs said on Friday the agency is putting out bids for “purchased care” that would allow veterans to be treated at other hospitals at the VA’s expense while cutting backlogs at its facilities.

Continue Reading On http://www.reuters.com »




No down payment medical, dental and healthcare provider practice financing here! + More News: U.S. FDA approves Biogen's hemophilia A drug Eloctate + MORE 06/07/2014

No comments: